LIPID-LOWERING EFFICACY OF 20 MG SIMVASTATIN VERSUS 5 MG ROSUVASTATIN IN PATIENTS OF TYPE 2 DIABETES

LIPID-LOWERING EFFICACY OF 20 MG SIMVASTATIN VERSUS 5 MG ROSUVASTATIN IN PATIENTS OF TYPE 2 DIABETES

Abstract Objective: To compare the efficacy of Rosuvastatin 5mg and Simvastatin 20mg in reducing low-density lipoprotein cholesterol in newly diagnosed patients with type 2 diabetes. Study Design: Quasi-experimental study. Place and Duration of Study: Department of General Medicine, Pak Emira...

Full description

Bibliographic Details
Main Authors:	Hafiz Muhammad Yasir Rehman, Abdul Latif Khattak, Taimoor Ashraf Khan, Abdul Moueed Tariq, Shahzeb Ahmed Satti, Rafi Ud Din
Format:	Article
Language:	English
Published:	Army Medical College Rawalpindi 2020-08-01
Series:	Pakistan Armed Forces Medical Journal
Subjects:	hmg-coa reductase inhibitor lipid-lowering efficacy low-density lipoprotein cholesterol rosuvastatin simvastatin
Online Access:	https://www.pafmj.org/index.php/PAFMJ/article/view/5050/2821

Similar Items

Simvastatin: between clinics and health economics
by: Francesco Vittorio Costa, et al.
Published: (2007-03-01)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
by: Masadeh Majed, et al.
Published: (2012-05-01)

Simvastatin Sensitizes Radioresistant Prostate Cancer Cells by Compromising DNA Double-Strand Break Repair
by: Yu-An Chen, et al.
Published: (2018-06-01)

Influence of simvA glyzin on expression and inhibition of hmg-coa reductase in rats liver
by: Yu. I. Ragino, et al.
Published: (2015-06-01)

Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study
by: Toivo Laks, et al.
Published: (2008-12-01)

Differential Renoprotective Actions of Simvastatin and Rosuvastatin in Streptozotocin-Induced Diabetes in Sprague-Dawley Rat
by: Rowaida Refaat, et al.
Published: (2020-06-01)

Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis
by: Myriam Jaam, et al.
Published: (2023-02-01)

Simvastatin Resistance of <i>Leishmania amazonensis</i> Induces Sterol Remodeling and Cross-Resistance to Sterol Pathway and Serine Protease Inhibitors
by: Thais Tenorio Soares Fujii, et al.
Published: (2022-02-01)

Evaluation of Antidiabetic potential and Hypolipidemic activity of Coccinia indica (leaves) in Diabetic Albino rats
by: Mamata Pochhi
Published: (2019-07-01)

Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test
by: Dick C. Chan, et al.
Published: (2002-05-01)

A comparison of the effectiveness of rosuvastatin, atorvastatin and simvastatin in achieving target lipid levels (according to the PROFILE-I registry)
by: Oleg V Gaisenok
Published: (2017-12-01)

Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient rats
by: Jose Marcos Girardi, et al.
Published: (2011-01-01)

Simvastatin profoundly impairs energy metabolism in primary human muscle cells
by: Selina Mäkinen, et al.
Published: (2020-12-01)

Hypoglycemic and antihyperlipidemic effect of aqueous leaves extract of Ficus Religiosa in alloxan induced diabetic rats
by: Mamata Pochhi
Published: (2017-03-01)

Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia
by: Yu-An Chen, et al.
Published: (2018-03-01)

Are statins toxic or safe for kidney diseases? An updated mini-review study
by: Shadi Botshekan, et al.
Published: (2020-10-01)

Hesperidin Interaction with HMG-CoA-Reductase Enzyme in Hypercholesterolemia: A Study in Silico
by: Annisa Rizqi Dwi Oktaviani, et al.
Published: (2021-09-01)

Isolation and purification of 3-hydroxy-3-methylglutaryl-coenzyme A by ion-exchange chromatography
by: I P Williamson, et al.
Published: (1981-01-01)

The quantitative assay of 3-hydroxy-3-methylglutaryl coenzyme A reductase: comparison of a thin-layer chromatographic assay with a rapid chloroform extraction assay
by: M E Ackerman, et al.
Published: (1977-05-01)

Estatinas hipolipêmicas e novas tendências terapêuticas Hypolipemic statins and new therapeutcal trends
by: Vanessa Leiria Campo, et al.
Published: (2007-04-01)

Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
by: Andrey Sivkov, et al.
Published: (2021-11-01)

PCSK9 Induces Rat Smooth Muscle Cell Proliferation and Counteracts the Pleiotropic Effects of Simvastatin
by: Maria Giovanna Lupo, et al.
Published: (2021-04-01)

Beneficial Effects of Statins on Seizures Independent of Their Lipid-Lowering Effect: A Narrative Review
by: Arash Amanlou, et al.
Published: (2023-01-01)

Statins—From Fungi to Pharmacy
by: Anna Sadowska, et al.
Published: (2023-12-01)

Statins in clinical medicine
by: Swiss Medical Weekly
Published: (2011-11-01)

3-Hydroxy-3-methylglutaryl coenzyme A reductase in isolated villous and crypt cells of the rat ileum
by: J L Merchant, et al.
Published: (1977-11-01)

Parallel regulation of sterol regulatory element binding protein-2 and the enzymes of cholesterol and fatty acid synthesis but not ceramide synthesis in cultured human keratinocytes and murine epidermis
by: Ian R. Harris, et al.
Published: (1998-02-01)

Lagenaria siceraria ameliorates atheromatous lesions by modulating HMG–CoA reductase and lipoprotein lipase enzymes activity in hypercholesterolemic rats
by: Mithun Singh Rajput, et al.
Published: (2014-01-01)

Cholesterol and sphingomyelin syntheses are regulated independently in cultured human intestinal cells, CaCo-2: role of membrane cholesterol and sphingomyelin content.
by: Heshun Chen, et al.
Published: (1993-12-01)

Gene expression of sterol regulatory element-binding proteins in hamster small intestine
by: F. Jeffrey Field, et al.
Published: (2001-01-01)

Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease
by: Yuanyuan Xu, et al.
Published: (2017-04-01)

The effect of the various doses of atorvastatin on renal tubular cells; an experimental study
by: Hamid Nasri, et al.
Published: (2016-07-01)

Modulating Liver Cholesterol Metabolism by 3-Iodothyronamine
by: Nasrin KAZEMIPOUR, et al.
Published: (2017-07-01)

Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis
by: Man K.S. Lee, et al.
Published: (2022-07-01)

Pre and post-stroke use of statins improves stroke outcome
by: Majaz Moonis, et al.
Published: (2014-01-01)

Potential drug interactions with statins: Estonian register-based study
by: Gavronski Maia, et al.
Published: (2015-04-01)

SPAR – a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial
by: Michael B. Jameson, et al.
Published: (2019-12-01)

Simvastatin in the Prevention of Recurrent Pancreatitis: Design and Rationale of a Multicenter Triple-Blind Randomized Controlled Trial, the SIMBA Trial
by: Karina Cárdenas-Jaén, et al.
Published: (2021-02-01)

Lipid metabolism in cultured cells. XVI. Lipoprotein binding and HMG CoA reductase levels in normal and tumor virus-transformed human fibroblasts
by: J M Bailey, et al.
Published: (1977-07-01)

Efficacy and safety of Mertenil (rosuvastatin) 40 mg in patients with familial hypercholesterolemia
by: M Yu Zubareva, et al.
Published: (2014-06-01)